The nation of Zimbabwe has declined a substantial US healthcare agreement valued at $367m (£272m) spanning five years due to the United States' request for confidential biological samples.
This rejection came to light after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesperson has since stated that the United States was requesting biological samples for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to secure a agreement acceptable to both sides so the country's critical HIV programme can continue.
Broader Implications
This development follows a comparable case in Kenya, where a high court blocked a similar health funding agreement after legal challenges were raised about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government agreements to boost openness and accountability.
Based on statements, Sixteen African countries have to date signed similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our people should a new pandemic emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures previously set up via the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This framework is designed to ensure that when a country provides its data, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent collaboration could be arranged in a manner that respects the independence and dignity of both nations."
Health Experts Reaction
A leading public health body said it acknowledged the official position, but urged that negotiations need to persist considering much of the country's HIV programmes relied on international support.
"In cases where technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group commented.
The halted deal highlights the ongoing challenges between receiving much-needed international aid and safeguarding a country's data in an increasingly data-driven world.